Last reviewed · How we verify
NCT05958316
Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer
NA trial testing Computerized Symptom Capture Tool (C-SCAT) Intervention in Symptoms and Signs in 126 participants. Currently enrolling.
31 August 2027
Quick facts
| Lead sponsor | Virginia Commonwealth University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 126 |
| Start date | 4 January 2024 |
| Primary completion | 31 August 2027 |
| Estimated completion | 31 August 2027 |
| Sites | 5 locations across United States |
Drugs / interventions tested
- Computerized Symptom Capture Tool (C-SCAT) Intervention
- Usual Care Control
Conditions studied
- Symptoms and Signs — all drugs for Symptoms and Signs →
- Cancer — all drugs for Cancer →
- Childhood Cancer — all drugs for Childhood Cancer →
Sponsor
Virginia Commonwealth University
Who can join
Adults 15 to 29, any sex, with Symptoms and Signs or Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Determine the effects of the Computerized Symptom Assessment Tool (C-SCAT) versus usual care on the primary outcomes of self-efficacy for symptom management and symptom self-management behaviors
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05958316
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Symptoms and Signs
Currently open trials in the same condition.
- NCT06136221 — Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease · NA · recruiting
- NCT06317714 — Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs · recruiting
- NCT05827406 — A Useful Support System for Psychiatric Diagnostics and Follow-up in Adult Psychiatry and Primary Care (ASPP) · recruiting
- NCT05505188 — Predictive and Impact of Pain After 6 Months of Radiotherapy, in Head and Neck Cancer · NA · recruiting
- NCT04347759 — Symptom Care at Home-Heart Failure · NA · recruiting
Other Virginia Commonwealth University trials
Trials by the same sponsor.
- NCT05936931 — Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening · NA · not yet recruiting
- NCT07365839 — Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma · Phase 1 · not yet recruiting
- NCT07178158 — Enhancing Addiction Treatment Through Psychoeducation · NA · not yet recruiting
- NCT07531316 — Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers · Phase 1 · not yet recruiting
- NCT07426913 — Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05958316 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Virginia Commonwealth University
- Last refreshed: 13 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05958316.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing